About Cotec Healthcare IPO
Cotec Healthcare IPO Details
The Cotec Healthcare IPO is a 100% book-built issue, comprising a fresh issue of ₹295 crore and an offer for sale (OFS) of 55 lakh equity shares, with a face value of ₹5 per share. The company filed its DRHP with SEBI on September 10, 2025.
The price band and official dates of subscription and listing will be announced by the company later, but the shares are intended to be listed on the BSE and the NSE platforms. The book-running lead manager of this issue is Pantomath Capital Advisors Private Ltd., while the registrar to the issue is KFin Technologies Ltd.
Cotec Healthcare IPO Date & Timeline
Cotec Healthcare Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on September 10, 2025; however, the specific IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalize the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding, and the final listing on the exchange will be formally disclosed.
Cotec Healthcare IPO Timeline
| IPO Open Date | - |
| IPO Close Date | - |
| Tentative Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Tentative Listing Date | - |
| Cut-off time for UPI mandate confirmation | - |
Cotec Healthcare IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹ 5 per Equity Share |
| Issue Price Band | - |
| Lot Size | - |
| Sale Type | Fresh Issue and Offer for Sale (OFS) |
| Total Issue Size | Up to [●] Equity Shares (Aggregating up to ₹ 295.00 Cr Fresh Issue + OFS portion) |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | Up to [●] Equity Shares (Aggregating up to ₹ 295.00 Cr) |
| Offer for Sale | Up to 60,00,000 Equity Shares |
| Net Offered to Public | - |
| Issue Type | 100 % Book Built Offer |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 11,42,06,346 shares |
| Share Holding Post Issue | - |
Cotec Healthcare IPO GMP (Grey Market Premium)
“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.
The Cotec Healthcare IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
Company Background
Cotec Healthcare Ltd. was incorporated on December 22, 1998, with a specialized focus on pharmaceutical manufacturing. Cotec Healthcare Ltd. has steadily evolved into an established player in the contract manufacturing and development (CDMO) sector.
The company’s headquarters have remained at Roorkee, Uttarakhand, and it has consistently developed and enhanced its capabilities as a healthcare solutions provider. By investing heavily in technology and quality assurance, it has transformed from being a regional player to being a one-stop solution for pharmaceutical formulations, serving a wide range of B2B clients.
Operations & Product Range
Cotec Healthcare Ltd. operates in the pharmaceutical manufacturing industry, which is highly regulated. The company’s operations are primarily based on contract manufacturing of a wide variety of pharmaceutical formulations. The main products of the company are highly diversified, catering to different segments of the pharmaceutical industry. By maintaining high standards of hygiene, the company meets the requirements of large and mid-sized pharmaceutical marketing companies.
Facilities & Capacity
The main facility of Cotec Healthcare Ltd. is its manufacturing unit located on the Roorkee-Dehradun Highway in Bhagwanpur, Haridwar. The company has specialized technology for large-scale pharmaceutical formulation manufacturing. The facility’s favorable location in a pharma-centric region supports operational efficiency, and upgrades are ongoing to meet growing client demand.
Brands & Market Presence
Cotec Healthcare Ltd. is a Contract Manufacturing Organisation (CMO) that specializes in the B2B pharmaceuticals segment, forming a critical part of the supply chain for existing brands. With a significant presence in India, the company generates substantial business from pharmaceutical marketing companies. Approval of the Roorkee facility enhances quality focus, making the company a preferred choice in the competitive pharmaceutical segment.
Revenue Streams & Business Model
Cotec Healthcare Ltd. generates revenue primarily through large-scale contract manufacturing and sale of pharmaceutical formulations. Operating on a B2B model, the company relies on long-term manufacturing agreements and recurring orders from clients.
The business model is scalable, leveraging specialized skills to manufacture medicines marketed by other pharmaceutical companies. Revenue mainly comes from local clients, with strategic efforts underway to optimize production lines for consistent revenue generation.
Management & Shareholding
Cotec Healthcare Ltd. is driven by a committed promoter group, including Harsh Tiwari and Vandana Tiwari. Before the IPO, the promoter group held a dominant shareholding. The IPO will dilute the promoter's shareholding, but they will retain a substantial majority stake to maintain strategic direction continuity.
Board & Key Management
The strategic and operational execution of Cotec Healthcare Ltd. is managed through a well-structured Board of Directors and key management personnel. Promoters are actively involved in executive leadership to drive growth. A well-composed board ensures corporate governance and unbiased decision-making. CS Jyoti Sachdeva manages compliance and secretarial aspects.
Cotec Healthcare IPO Financial Information
Latest Revenue
192.87
₹ Crore
Profit After Tax
20.00
₹ Crore
Net Worth
58.97
₹ Crore
Total Borrowing
26.07
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| Fiscal 2025 | 136.63 | 192.87 | 20.00 | 58.97 | 58.46 | 26.07 | |||
| Fiscal 2024 | 95.83 | 138.44 | 10.46 | 38.90 | 38.39 | 15.49 | |||
| Fiscal 2023 | 68.65 | 82.66 | 5.03 | 28.34 | 27.83 | 11.24 | |||
| Amount in ₹ Crore | |||||||||
Cotec Healthcare Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | - |
| ROCE | 36.43% |
| Debt/Equity | 0.44x |
| RoNW | 33.91% |
| PAT Margin | 10.40% |
| EBITDA Margin | 16.36% |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | ₹1.75 | [.] |
| P/E (x) | [.] | [.] |
Cotec Healthcare IPO Objectives
The company plans to utilize the Cotec Healthcare IPO proceeds from the fresh issue for the following strategic objectives:
- • Funding capital expenditure for upgrading or setting up new manufacturing capabilities
- • Funding working capital requirements
- • Repayment or prepayment of debt
- • General corporate purposes
Cotec Healthcare IPO Review
Cotec Healthcare Ltd. is well-established in the high-growth pharmaceutical contract manufacturing (CDMO) sector, which benefits from the increasing growth in the domestic healthcare industry. Outsourced manufacturing remains a critical operational strategy for numerous pharmaceutical marketing firms. The Uttarakhand facility provides operational scale to tap into sector demand.
Financially, the proceeds will be used for capital expenditures, working capital, and debt repayment, reflecting management's focus on scaling operations and strengthening the balance sheet. This capital infusion enhances manufacturing capabilities, technological infrastructure, and operational capacity to meet larger client requirements.
The pharmaceutical manufacturing segment is under strict regulatory and quality scrutiny. Any lapse could result in significant client loss. The company also faces competition from other established CDMOs in India. The Cotec Healthcare IPO provides investors a targeted opportunity within the pharmaceutical supply chain, leveraging established manufacturing capabilities and growth potential.
Conclusion
Cotec Healthcare IPO offers investors a chance to invest in a growing company with a reliable B2B manufacturing model, high-quality pharmaceutical formulations, and strong client relationships. The IPO aims to fund operational expansion and working capital, with future performance reliant on successful execution of expansion plans and navigating the highly regulated pharmaceutical industry.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
A track record of being a highly dependable contract manufacturer in the pharmaceutical industry.
A strategically located manufacturing facility in Roorkee provides optimised supply chain efficiencies.
Diverse product portfolio across various segments of therapy and advanced drug delivery systems.
Well-established relationships with B2B pharmaceutical industry clients.
| Sr.no | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 10/09/2025 | View DRHP |
| 2 | SEBI/Exchange approval received | - | - |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | 0 | 1400015000 |
| Individual investors (Retail) (Max) | 0 | 0 | 200000 |
| S-HNI (Min) | 0 | 0 | 200000 |
| S-HNI (Max) | 0 | 0 | 1000000 |
| B-HNI (Min) | 0 | 0 | 1000000 |